Field Reimbursement and Market Access Manager

United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Robotics, Healthcare, Medical DevicesIndustries

Requirements

Candidates must possess a Bachelor of Arts or Science degree, or an equivalent combination of experience and education. A minimum of 5 years of experience in medical device reimbursement and/or health economics is required, along with demonstrated knowledge of US private payers and Medicare coverage and payment. Excellent interpersonal, communication, and presentation skills are essential for influencing stakeholders, resolving conflicts, and problem-solving. Previous experience collaborating with field sales teams and comfort with virtual work environments are necessary. The ability to manage complex problems and projects independently, with strong analytical thinking and minimal supervision, is crucial. This field-based role requires the ability to travel up to 60% of the time, and proximity to a major airport is a plus.

Responsibilities

The Field Reimbursement and Market Access Manager will manage and execute reimbursement strategies to ensure patient access to therapy and optimize market access for Aquablation. Responsibilities include educating and training hospitals and practices on coding, coverage, payment, and patient authorization processes, and organizing reimbursement education meetings for existing customers. The role involves serving as the primary ongoing reimbursement resource for customers, collaborating closely with field sales teams, and assisting patients with insurance coverage and payer appeals. Additionally, the manager will solicit, analyze, and present customer financial data during business reviews.

Skills

Reimbursement Strategies

Market Access

Coding

Coverage

Payment

Patient Authorization

Healthcare

Robotics

Sales Support

Customer Education

PROCEPT BioRobotics

Develops robotic solutions for BPH treatment

About PROCEPT BioRobotics

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, focusing on enhancing patient outcomes and making surgical procedures more efficient. Unlike competitors, PROCEPT BioRobotics emphasizes predictable results and reduced complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to improve the quality of life for patients suffering from BPH through advanced surgical solutions.

Redwood City, CaliforniaHeadquarters

2009Year Founded

$319.1MTotal Funding

IPOCompany Stage

Robotics & Automation, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Parental Leave

Paid Holidays

Wellness Program

Gym Membership

Risks

Competition from Intuitive Surgical and Medtronic may impact market share.

$175 million public stock offering could lead to shareholder dilution.

Reliance on AquaBeam System makes company vulnerable to technological failures.

Differentiation

AquaBeam Robotic System offers image-guided, minimally invasive urologic surgery.

Aquablation therapy provides effective outcomes regardless of prostate size or surgeon experience.

PROCEPT has over 100 peer-reviewed publications supporting Aquablation therapy's benefits.

Upsides

Increasing adoption of robotic-assisted surgeries boosts demand for AquaBeam System.

Global urology devices market projected to grow at 6.9% CAGR until 2030.

FDA's supportive regulatory environment favors innovative medical technologies like PROCEPT's.

Land your dream remote job 3x faster with AI

Try Jobo Free